NICE - ナイス・システムズ (NICE Ltd)

NICEのニュース

   $1.38 Earnings Per Share Expected for NICE Ltd. (NASDAQ:NICE) This Quarter  2020/10/25 04:12:58 US Banking News
Analysts expect that NICE Ltd. (NASDAQ:NICE) will post earnings per share of $1.38 for the current quarter, Zacks reports. Four analysts have provided estimates for NICE’s earnings, with the lowest EPS estimate coming in at $1.36 and the highest estimate coming in at $1.40. NICE posted earnings of $1.30 per share during the same quarter […]
   NICE Ltd. (NASDAQ:NICE) Given Consensus Recommendation of “Hold” by Analysts  2020/10/22 07:35:13 Dispatch Tribunal
NICE Ltd. (NASDAQ:NICE) has earned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective […]
   NICE Announces Proposed Offering of $400,000,000 of Convertible Senior Notes Due 2025  2020/08/24 11:23:00 Business Wire
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE Ltd. (NASDAQ: NICE) (the "Company") announced today that it intends to offer, subject to market and other considerations, $400,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an additional $60,000,000 aggreg
   Can you really beat pain without drugs?  2020/08/10 21:35:11 Daily Mail Online
The National Institute for Health and Care Excellence (NICE) last week warned that pills including paracetamol, should no longer be routinely prescribed to patients with chronic pain.
   Common painkillers should not be used for chronic pain, study suggests  2020/08/05 07:43:59 Inquirer Technology
According to a new study, aspirin, ibuprofen and paracetamol, common painkillers we are used to taking for mild fever or aches and pains, may cause more harm than good in the treatment of chronic pain. In a draft guideline published on Monday, Aug. 3, the United Kingdom's National Institute for Health and Care Excellence (Nice) announced that there is "little or no evidence" of the efficacy of commonly used medicines against primary chronic pain, which is defined as pain that lasts or reappears for longer than three months and is caused by physical incapacity or emotional distress. According to the announcement, analgesics don't diminish pain, improve quality of life or minimiz… Keep on reading: Common painkillers should not be used for chronic pain, study suggests
   $1.38 Earnings Per Share Expected for NICE Ltd. (NASDAQ:NICE) This Quarter  2020/10/25 04:12:58 US Banking News
Analysts expect that NICE Ltd. (NASDAQ:NICE) will post earnings per share of $1.38 for the current quarter, Zacks reports. Four analysts have provided estimates for NICE’s earnings, with the lowest EPS estimate coming in at $1.36 and the highest estimate coming in at $1.40. NICE posted earnings of $1.30 per share during the same quarter […]
   NICE Ltd. (NASDAQ:NICE) Given Consensus Recommendation of “Hold” by Analysts  2020/10/22 07:35:13 Dispatch Tribunal
NICE Ltd. (NASDAQ:NICE) has earned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective […]
   NICE Announces Proposed Offering of $400,000,000 of Convertible Senior Notes Due 2025  2020/08/24 11:23:00 Business Wire
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE Ltd. (NASDAQ: NICE) (the "Company") announced today that it intends to offer, subject to market and other considerations, $400,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an additional $60,000,000 aggreg
   Can you really beat pain without drugs?  2020/08/10 21:35:11 Daily Mail Online
The National Institute for Health and Care Excellence (NICE) last week warned that pills including paracetamol, should no longer be routinely prescribed to patients with chronic pain.
   Common painkillers should not be used for chronic pain, study suggests  2020/08/05 07:43:59 Inquirer Technology
According to a new study, aspirin, ibuprofen and paracetamol, common painkillers we are used to taking for mild fever or aches and pains, may cause more harm than good in the treatment of chronic pain. In a draft guideline published on Monday, Aug. 3, the United Kingdom's National Institute for Health and Care Excellence (Nice) announced that there is "little or no evidence" of the efficacy of commonly used medicines against primary chronic pain, which is defined as pain that lasts or reappears for longer than three months and is caused by physical incapacity or emotional distress. According to the announcement, analgesics don't diminish pain, improve quality of life or minimiz… Keep on reading: Common painkillers should not be used for chronic pain, study suggests
   $1.38 Earnings Per Share Expected for NICE Ltd. (NASDAQ:NICE) This Quarter  2020/10/25 04:12:58 US Banking News
Analysts expect that NICE Ltd. (NASDAQ:NICE) will post earnings per share of $1.38 for the current quarter, Zacks reports. Four analysts have provided estimates for NICE’s earnings, with the lowest EPS estimate coming in at $1.36 and the highest estimate coming in at $1.40. NICE posted earnings of $1.30 per share during the same quarter […]
   NICE Ltd. (NASDAQ:NICE) Given Consensus Recommendation of “Hold” by Analysts  2020/10/22 07:35:13 Dispatch Tribunal
NICE Ltd. (NASDAQ:NICE) has earned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective […]
   NICE Announces Proposed Offering of $400,000,000 of Convertible Senior Notes Due 2025  2020/08/24 11:23:00 Business Wire
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE Ltd. (NASDAQ: NICE) (the "Company") announced today that it intends to offer, subject to market and other considerations, $400,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an additional $60,000,000 aggreg
   Can you really beat pain without drugs?  2020/08/10 21:35:11 Daily Mail Online
The National Institute for Health and Care Excellence (NICE) last week warned that pills including paracetamol, should no longer be routinely prescribed to patients with chronic pain.
   Common painkillers should not be used for chronic pain, study suggests  2020/08/05 07:43:59 Inquirer Technology
According to a new study, aspirin, ibuprofen and paracetamol, common painkillers we are used to taking for mild fever or aches and pains, may cause more harm than good in the treatment of chronic pain. In a draft guideline published on Monday, Aug. 3, the United Kingdom's National Institute for Health and Care Excellence (Nice) announced that there is "little or no evidence" of the efficacy of commonly used medicines against primary chronic pain, which is defined as pain that lasts or reappears for longer than three months and is caused by physical incapacity or emotional distress. According to the announcement, analgesics don't diminish pain, improve quality of life or minimiz… Keep on reading: Common painkillers should not be used for chronic pain, study suggests

calendar